论文部分内容阅读
目的:探讨康复新联合三联抗幽门螺杆菌治疗消化性溃疡的临床效果。方法:选取我院自收治的84例消化性溃疡患者,随机将其分为观察组和对照组,各42例,给予对照组患者口服奥美拉唑配合奥硝唑及阿莫西林治疗,观察组患者在对照组治疗的基础上加用康复新治疗,对两组患者的治疗总有效率、不良反应发生情况进行对比。结果:观察组患者的治疗总有效率为95.24%,对照组患者的治疗总有效率为78.57%,观察组明显高于对照组(P<0.05),两组患者不良反应发生率比较无统计学意义(P>0.05)。结论:在三联抗幽门螺杆菌治疗的基础上给予消化性溃疡患者康复新治疗可有效的提高效果,且不良反应少,临床效果显著,值得推广和应用。
Objective: To investigate the clinical effect of rehabilitation combined with triple anti-Helicobacter pylori in the treatment of peptic ulcer. Methods: Eighty-four patients with peptic ulcer admitted to our hospital were randomly divided into observation group and control group, 42 cases in each group. Patients in the control group were treated with omeprazole combined with ornidazole and amoxicillin. Group patients in the control group based on the treatment of rehabilitation plus new treatment, the two groups of patients treated with total efficiency, adverse reactions were compared. Results: The total effective rate was 95.24% in the observation group and 78.57% in the control group, which was significantly higher in the observation group than in the control group (P <0.05). There was no statistical difference in the incidence of adverse reactions between the two groups Significance (P> 0.05). Conclusion: The new rehabilitation treatment of patients with peptic ulcer on the basis of triple anti-Helicobacter pylori treatment can effectively improve the effect with less adverse reactions and significant clinical effect, which is worthy of promotion and application.